Akèy › Limfom Difize Gwo Selil B › Iowa › Cedar Rapids
Etid klinik pou Limfom Difize Gwo Selil B nan Cedar Rapids, IA
9 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Cedar Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Ap rekriteFaz 2
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Ap rekriteFaz 1/2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi lwen
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Ap rekriteFaz 2
- University of Iowa-Holden Comprehensive Cancer Center ( Site 0139), Iowa City · 25 mi lwen
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Ap rekriteFaz 1
- University of Iowa, Iowa City · 25 mi lwen
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Ap rekriteFaz 1/2
- University of Iowa-Holden Comprehensive Cancer Center ( Site 1017), Iowa City · 25 mi lwen
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Ap rekriteFaz 1/2
- University of Iowa, Iowa City · 25 mi lwen
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Ap rekriteFaz 3
- University of Iowa, Iowa City · 25 mi lwen
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Ap rekriteFaz 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Ap rekriteFaz 2
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Etid Limfom Difize Gwo Selil B nan lòt vil
- New York City, NY21 etid
- Baldwin Park, CA19 etid
- Chicago, IL18 etid
- Houston, TX17 etid
- Los Angeles, CA17 etid
- Boston, MA16 etid
- Milwaukee, WI16 etid
- Philadelphia, PA15 etid
- Portland, OR15 etid
- Durham, NC14 etid
- Nashville, TN14 etid
- Dallas, TX13 etid
Lòt etid nan Cedar Rapids
- Kansè Poumon ki pa ti selil20 etid
- Kansè nan tete17 etid
- Leksemi mieloïd egi16 etid
- Kansè (tout kalite)15 etid
- Myelom Miltip15 etid
- Kansè poumon14 etid
- Kansè kolorektal13 etid
- Karsinòm selil skuamèz tèt ak kou12 etid
- Kansè pwostat12 etid
- Akidan serebavaskilè10 etid
- Melanom10 etid
- Kansè Endomèt9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.